These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 7905945

  • 1. Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect.
    Verma A, Kulkarni SK, Nayar U.
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):515-25. PubMed ID: 7905945
    [Abstract] [Full Text] [Related]

  • 2. Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice.
    Verma A, Kulkarni SK.
    Indian J Exp Biol; 1991 Feb; 29(2):123-6. PubMed ID: 1831182
    [Abstract] [Full Text] [Related]

  • 3. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C, Abraini JH, David HN.
    Hippocampus; 2007 Feb; 17(11):1028-36. PubMed ID: 17604350
    [Abstract] [Full Text] [Related]

  • 4. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM, Bruno JP.
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR, Bunney BS.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [Abstract] [Full Text] [Related]

  • 6. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 7. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P, Abercrombie ED.
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [Abstract] [Full Text] [Related]

  • 8. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
    Boldry RC, Chase TN, Engber TM.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1454-9. PubMed ID: 7903390
    [Abstract] [Full Text] [Related]

  • 9. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
    Jiang LH, Kasser RJ, Altar CA, Wang RY.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1198-205. PubMed ID: 1972751
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain.
    Undie AS, Friedman E.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):987-92. PubMed ID: 1972756
    [Abstract] [Full Text] [Related]

  • 11. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M, Danek L, Smiałowski A.
    Pol J Pharmacol Pharm; 1988 Jun; 40(5):535-41. PubMed ID: 2908137
    [Abstract] [Full Text] [Related]

  • 12. Effect of dopaminergic drugs on the reserpine-induced lowering of hippocampal theta wave frequency in rats.
    Nakagawa T, Ukai K, Ohyama T, Gomita Y, Okamura H.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):71-6. PubMed ID: 11062864
    [Abstract] [Full Text] [Related]

  • 13. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD, Pierce RC.
    Neuroscience; 2006 Oct 13; 142(2):451-61. PubMed ID: 16844308
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Interactions of GABAergic and catecholaminergic neurotransmissions. Effects of dopaminergic and noradrenergic agonists and antagonists on GABA turnover].
    Bernasconi R, Steulet AF, Aryee D, Martin P, Leonhardt T, Bischoff S, Maitre L.
    Encephale; 1989 Oct 13; 15(4):377-85. PubMed ID: 2572414
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun 13; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
    Ruskin DN, Rawji SS, Walters JR.
    J Pharmacol Exp Ther; 1998 Jul 13; 286(1):272-81. PubMed ID: 9655869
    [Abstract] [Full Text] [Related]

  • 20. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct 13; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.